Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII

Yuko Kamata, Torayuki Okuyama, Motomichi Kosuga, Aya O'hira, Arihiko Kanaji, Kyoko Sasaki, Masao Yamada, Noriyuki Azuma

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Recent advances in systemic treatments for mucopolysaccharidosis have led to therapies that improve the multiple somatic features of this disease, but the therapeutic effect on ocular manifestations such as corneal clouding is not satisfactory. Here, we administered an adenovirus expressing human β-glucuronidase (AxCAhGUS) into the anterior chamber or intrastromal region of the cornea in mice with mucopolysaccharidosis type VII (B6/MPSVII), and successfully treated corneal clouding of MPSVII. When we injected AxCAhGUS into the anterior chamber of the eyes, cells expressing β-glucuronidase (GUSB) were located mainly in the trabecular meshwork as well as in all corneal regions, and subsequent pathological corrections in the cornea were achieved. Widespread transgene expression was also observed when we administered AxCAhGUS inside the cornea after lamellar keratotomy, and rapid elimination of the lysosomal storage in the corneal keratocytes occurred. Furthermore, intrastromal vector administration did not generate significant levels of anti-adenovirus neutralizing antibodies, and secondary vector administration was effective. Based on these observations, we conclude that it is worth developing a treatment strategy for corneal clouding in mucopolysaccharidosis based on direct intraocular administration of adenoviral vectors.

Original languageEnglish
Pages (from-to)307-312
Number of pages6
JournalMolecular Therapy
Volume4
Issue number4
DOIs
Publication statusPublished - 2001 Jan 1
Externally publishedYes

Keywords

  • Adenovirus
  • Corneal clouding
  • Mucopolysaccharidosis

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery

Fingerprint Dive into the research topics of 'Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII'. Together they form a unique fingerprint.

  • Cite this

    Kamata, Y., Okuyama, T., Kosuga, M., O'hira, A., Kanaji, A., Sasaki, K., Yamada, M., & Azuma, N. (2001). Adenovirus-mediated gene therapy for corneal clouding in mice with mucopolysaccharidosis type VII. Molecular Therapy, 4(4), 307-312. https://doi.org/10.1006/mthe.2001.0461